Pharmacological  ||| S:0 E:16 ||| JJ
treatment  ||| S:16 E:26 ||| NN
of  ||| S:26 E:29 ||| IN
impulsivity  ||| S:29 E:41 ||| NN
and  ||| S:41 E:45 ||| CC
aggressive  ||| S:45 E:56 ||| JJ
behavior  ||| S:56 E:65 ||| NN
Impulsivity  ||| S:65 E:77 ||| NNP
and  ||| S:77 E:81 ||| CC
aggressive  ||| S:81 E:92 ||| JJ
behavior  ||| S:92 E:101 ||| NN
occur  ||| S:101 E:107 ||| VBP
frequently  ||| S:107 E:118 ||| RB
in  ||| S:118 E:121 ||| IN
a  ||| S:121 E:123 ||| DT
variety  ||| S:123 E:131 ||| NN
of  ||| S:131 E:134 ||| IN
psychiatric  ||| S:134 E:146 ||| JJ
disorders  ||| S:146 E:156 ||| NNS
and  ||| S:156 E:160 ||| CC
neurological  ||| S:160 E:173 ||| JJ
diseases ||| S:173 E:181 ||| NNS
.  ||| S:181 E:183 ||| .
Two  ||| S:183 E:187 ||| CD
lines  ||| S:187 E:193 ||| NNS
of  ||| S:193 E:196 ||| IN
treatment  ||| S:196 E:206 ||| NN
could  ||| S:206 E:212 ||| MD
be  ||| S:212 E:215 ||| VB
employed ||| S:215 E:223 ||| VBN
,  ||| S:223 E:225 ||| ,
the  ||| S:225 E:229 ||| DT
treatment  ||| S:229 E:239 ||| NN
of  ||| S:239 E:242 ||| IN
the  ||| S:242 E:246 ||| DT
disorder  ||| S:246 E:255 ||| NN
or  ||| S:255 E:258 ||| CC
disease  ||| S:258 E:266 ||| NN
in  ||| S:266 E:269 ||| IN
which  ||| S:269 E:275 ||| WDT
these  ||| S:275 E:281 ||| DT
symptoms  ||| S:281 E:290 ||| NNS
occur  ||| S:290 E:296 ||| VBP
or  ||| S:296 E:299 ||| CC
the  ||| S:299 E:303 ||| DT
treatment  ||| S:303 E:313 ||| NN
of  ||| S:313 E:316 ||| IN
the  ||| S:316 E:320 ||| DT
impulsivity  ||| S:320 E:332 ||| NN
and  ||| S:332 E:336 ||| CC
aggressive  ||| S:336 E:347 ||| JJ
behavior  ||| S:347 E:356 ||| NN
itself ||| S:356 E:362 ||| PRP
.  ||| S:362 E:364 ||| .
This  ||| S:364 E:369 ||| DT
second  ||| S:369 E:376 ||| JJ
approach  ||| S:376 E:385 ||| NN
considers  ||| S:385 E:395 ||| VBZ
that  ||| S:395 E:400 ||| IN
there  ||| S:400 E:406 ||| EX
are  ||| S:406 E:410 ||| VBP
neurobiological  ||| S:410 E:426 ||| JJ
similarities  ||| S:426 E:439 ||| NNS
underlying  ||| S:439 E:450 ||| VBG
these  ||| S:450 E:456 ||| DT
behaviors  ||| S:456 E:466 ||| NN
regardless  ||| S:466 E:477 ||| RB
of  ||| S:477 E:480 ||| IN
the  ||| S:480 E:484 ||| DT
' ||| S:484 E:485 ||| POS
primary ||| S:485 E:492 ||| NN
'  ||| S:492 E:494 ||| POS
diagnoses  ||| S:494 E:504 ||| NN
with  ||| S:504 E:509 ||| IN
which  ||| S:509 E:515 ||| WDT
they  ||| S:515 E:520 ||| PRP
are  ||| S:520 E:524 ||| VBP
associated ||| S:524 E:534 ||| VBN
.  ||| S:534 E:536 ||| .
Imbalance  ||| S:536 E:546 ||| NN
between  ||| S:546 E:554 ||| IN
limbic  ||| S:554 E:561 ||| JJ
bottom-up  ||| S:561 E:571 ||| JJ
drives ||| S:571 E:577 ||| NNS
,  ||| S:577 E:579 ||| ,
exerted  ||| S:579 E:587 ||| VBN
by  ||| S:587 E:590 ||| IN
structures  ||| S:590 E:601 ||| NNS
like  ||| S:601 E:606 ||| IN
the  ||| S:606 E:610 ||| DT
amygdala ||| S:610 E:618 ||| NN
,  ||| S:618 E:620 ||| ,
and  ||| S:620 E:624 ||| CC
prefrontal  ||| S:624 E:635 ||| JJ
top-down  ||| S:635 E:644 ||| JJ
control  ||| S:644 E:652 ||| NN
mechanisms  ||| S:652 E:663 ||| NNS
could  ||| S:663 E:669 ||| MD
be  ||| S:669 E:672 ||| VB
the  ||| S:672 E:676 ||| DT
ultimate  ||| S:676 E:685 ||| JJ
reason  ||| S:685 E:692 ||| NN
for  ||| S:692 E:696 ||| IN
an  ||| S:696 E:699 ||| DT
aggressive-impulsive  ||| S:699 E:720 ||| JJ
behavior ||| S:720 E:728 ||| NN
.  ||| S:728 E:730 ||| .
The  ||| S:730 E:734 ||| DT
role  ||| S:734 E:739 ||| NN
of  ||| S:739 E:742 ||| IN
serotonin ||| S:742 E:751 ||| NN
,  ||| S:751 E:753 ||| ,
noradrenaline  ||| S:753 E:767 ||| NN
and  ||| S:767 E:771 ||| CC
dopamine  ||| S:771 E:780 ||| NNS
were  ||| S:780 E:785 ||| VBD
comprehensively  ||| S:785 E:801 ||| RB
investigated  ||| S:801 E:814 ||| VBN
with  ||| S:814 E:819 ||| IN
regards  ||| S:819 E:827 ||| VBG
to  ||| S:827 E:830 ||| TO
impulsive  ||| S:830 E:840 ||| VB
and  ||| S:840 E:844 ||| CC
aggressive  ||| S:844 E:855 ||| JJ
behavior  ||| S:855 E:864 ||| NN
and  ||| S:864 E:868 ||| CC
these  ||| S:868 E:874 ||| DT
neurochemical  ||| S:874 E:888 ||| JJ
data  ||| S:888 E:893 ||| NNS
were  ||| S:893 E:898 ||| VBD
further  ||| S:898 E:906 ||| RB
integrated  ||| S:906 E:917 ||| VBN
with  ||| S:917 E:922 ||| IN
the  ||| S:922 E:926 ||| DT
neuroanatomical  ||| S:926 E:942 ||| JJ
model ||| S:942 E:947 ||| NN
,  ||| S:947 E:949 ||| ,
providing  ||| S:949 E:959 ||| VBG
the  ||| S:959 E:963 ||| DT
bases  ||| S:963 E:969 ||| NNS
to  ||| S:969 E:972 ||| TO
the  ||| S:972 E:976 ||| DT
rational  ||| S:976 E:985 ||| JJ
pharmacological  ||| S:985 E:1001 ||| JJ
approach  ||| S:1001 E:1010 ||| NN
of  ||| S:1010 E:1013 ||| IN
these  ||| S:1013 E:1019 ||| DT
behaviors ||| S:1019 E:1028 ||| NN
.  ||| S:1028 E:1030 ||| .
